Inspire Medical Systems Inc (INSP)

Financial leverage ratio

		Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Total assets	US$ in thousands	796,194	728,389	685,842	676,811	639,494	618,246	571,847	564,876	527,523	292,002	289,720	295,084	278,894	272,208	273,413	281,189	271,784	271,308	165,736	181,253
Total stockholders’ equity	US$ in thousands	696,562	638,071	589,024	572,514	544,180	529,359	504,648	496,008	470,204	226,984	225,055	229,048	220,300	219,914	223,131	229,747	228,823	233,594	127,403	139,835
Financial leverage ratio		1.14	1.14	1.16	1.18	1.18	1.17	1.13	1.14	1.12	1.29	1.29	1.29	1.27	1.24	1.23	1.22	1.19	1.16	1.30	1.30

September 30, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $796,194K ÷ $696,562K
= 1.14

The financial leverage ratio of Inspire Medical Systems Inc has exhibited some fluctuations over the past few quarters, ranging from 1.12 to 1.30. The financial leverage ratio was relatively stable around 1.14 to 1.18 in the initial quarters of the period under review. However, there was a notable increase in the ratio to 1.29 in the quarter ending March 31, 2022, which was sustained for the following two quarters.

Subsequently, the ratio experienced a slight decline to 1.27 in the quarter ending December 31, 2022, before dropping further to 1.22 by the end of March 31, 2023. There was a subsequent increase to 1.24 by June 30, 2023, before peaking at 1.30 in the quarters ending September 30, 2022, and March 31, 2022. The ratio trended downwards to 1.19 by December 31, 2023, and continued to decrease to 1.14 as of September 30, 2024.

Overall, the financial leverage ratio of Inspire Medical Systems Inc has shown both upward and downward movements over the periods analyzed, reflecting changes in the company's capital structure and debt levels. It is essential for stakeholders to monitor this ratio over time to assess the company's risk and ability to meet its financial obligations.